Xolair 300 MG/2 ML autoinject 2ML

Ended Awarded

Contract number
SPE2DR26FCJH4
Awardee
Awarding agency
Obligated
$3,495

Award facts

Contract value 100% obligated
$3,494.88 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $3,494.88 delivery order to DMS Pharmaceutical Group Inc. on July 14, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for XOLAIR 300 MG/2 ML AUTOINJECT 2ML.

DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. The order has a firm fixed-price structure with an ultimate completion date of August 4, 2026. The order is issued under a single-award indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling running through December 31, 2036.

Quick answers

Who was awarded contract SPE2DR26FCJH4?

SPE2DR26FCJH4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2026.

How much is contract SPE2DR26FCJH4 worth?

The government has obligated $3,495 on SPE2DR26FCJH4.

Is contract SPE2DR26FCJH4 an order under another contract?

Yes. SPE2DR26FCJH4 is a delivery order under SPE2DR25D9113, an indefinite delivery contract.

Was contract SPE2DR26FCJH4 competed?

The extent of competition for SPE2DR26FCJH4 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login